The upregulation of STAU2, observed in T and B cells in human breast cancer patients may promote tumor growth through the RNA transport process of various inflammatory cytokine molecules suggesting its potential as a novel diagnostic biomarker for human breast cancer screening [31]. Here, STAU2 is linked to breast carcinoma.